MicroTech Medical (Hangzhou) Co (HKSE:02235) Margin of Safety % (DCF Dividends Based): N/A (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02235 MicroTech Medical (Hangzhou) Co Ltd HKSE:02235
80 GF Score
Price HK$7.26
GF Value HK$15.94
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is MicroTech Medical (Hangzhou) Co Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

MicroTech Medical (Hangzhou) Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

HKSE:02235 vs ABT, SYK, MDT: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroTech Medical (Hangzhou) Co Margin of Safety % (DCF Dividends Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Margin of Safety % (DCF Dividends Based) falls into.


HKSE:02235
80GF Score
MicroTech Medical (Hangzhou) Co Ltd HKSE:02235
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MicroTech Medical (Hangzhou) Co (HKSE:02235) Overvalued in 2026?

Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co stock appears to be undervalued. The current stock price of HK$7.26 is trading 54.5% below its estimated GF Value™ of HK$15.94. GuruFocus considers MicroTech Medical (Hangzhou) Co to be Possible Value Trap.

Key valuation signals for HKSE:02235:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: HK$15.94 vs. price of HK$7.26 (54.5% below fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the HKSE:02235 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MicroTech Medical (Hangzhou) Co Business Description

Address No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
MicroTech Medical (Hangzhou) Co Ltd is focused on diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve the diabetes management in China and globally. The Group operates in a large and fast-growing diabetes monitoring, treatment and management market in China and globally with unmet clinical needs. The company derives a majority of its revenue from China.
80GF Score

Get the complete analysis for HKSE:02235

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.26
Price
HK$15.94
GF Value